期刊文献+

MicroRNA-29a靶向抑制PTEN基因诱导非小细胞肺癌细胞上皮间质转化的机制研究 被引量:10

MicroRNA-29a promotes epithelial-mesenchymal transition in non-small cell lung cancer through down-regulating PTEN gene expression
下载PDF
导出
摘要 目的:探讨microRNA-29a(miR-29a)及其靶蛋白PTEN在TGF-β1诱导非小细胞肺癌(nonsmall cell lung cancer,NSCLC)细胞上皮间质转化(epithelial-mesenchymal transition,EMT)中的作用机制。方法:选择A549细胞经终浓度为10 ng/ml TGF-β1诱导48 h后,分为Blank组(不转染任何序列)、阴性对照(negative control,NC)组(转染阴性对照序列)、IN组(转染miR-29a inhibitors)、siRNA组(转染PTEN-siRNA)和IN+siRNA组(共转染miR-29a inhibitors和PTEN-siRNA)。普通显微镜观察各组细胞形态学变化;免疫荧光检测各组细胞中E-cadherin表达水平;qRT-PCR法检测EMT相关因子及PTEN mRNA表达水平;Western blotting法检测转染后EMT相关因子、PTEN、Akt和p-Akt蛋白的表达;划痕实验检测各组细胞迁移能力。构建裸鼠移植瘤模型,观察肿瘤生长,免疫组化检测裸鼠肿瘤组织中PTEN及EMT相关因子蛋白表达水平。结果:A549细胞转染miR-29a inhibitors后TGF-β1诱导细胞的上皮间质转化显著受到抑制,Ncadherin、Vimentin及Slug的mRNA和蛋白表达水平在IN组中显著低于Blank组和NC组,但在siRNA组和IN+siRNA组中显著上调(均P<0.05)。与Blank组和NC组相比,IN组PTEN mRNA和蛋白表达水平明显升高,且p-Akt的表达显著降低,细胞迁移率显著下降,而siRNA组和IN+siRNA组PTEN mRNA和蛋白表达明显降低,p-Akt的表达显著上升,细胞迁移率显著升高(均P<0.05)。裸鼠移植瘤实验结果显示与Blank组和NC组相比,IN组肿瘤生长较慢,重量降低,E-cadherin和PTEN蛋白表达显著升高,N-cadherin、β-catenin、Vimentin、Slug蛋白表达显著降低(均P<0.05)。结论:TGF-β1能诱导NSCLC细胞发生EMT,且能上调miR-29a并抑制PTEN的表达水平;抑制miR-29a的表达水平可能通过上调靶基因PTEN,促进Akt磷酸化,抑制EMT的发生。 ObjectiveTo explore the effects of microRNA -29a (miR -29a) and PTEN/Akt signaling pathway on TGF -β1 - induced epithelial - mesenchymal transition ( EMT) in non - small cell lung cancer ( NSCLC). Methods:After 48 h of treatment with TGF -β1 (10 ng/ml),the A549 cells were divided into the blank,negative control (NC) ,miR - 29a inhibitors (IN) , PTEN - siRNA and miR - 29a inhibitors + PTEN - siRNA groups. EMT related factors and PTEN expressions were detected by qRT - PCR assay and Western blotting. The scratch test was conduc-ted to observe cell migration. Xenograft tumor model in nude mice was used to evaluate the effects of miR - 29a on EMT of NSCLC cells in vivo. Results : In NSCLC tissues, the expressions of miR - 29a, Akt and p - Akt were up - reg-ulated, while PTEN expression was down - regulated. Gene and protein expressions of E - cadherin and PTEN in the miR - 29a inhibitors group were higher than the blank, NC, PTEN - siRNA and miR - 29a inhibitors + PTEN - siRNA groups,while the expressions of N - cadherin, p - catenin, Vimentin and Slug were higher than other groups. miR - 29a inhibitors significantly inhibit cell migration and invasion in NSCLC cell lines. In vivo xenograft experiment re-vealed that miR - 29a inhibitor inhibits the growth of transplanted tumor through up - regulating E - cadherin and PTEN expressions and down - regulating the expressions of N - cadherin, p - catenin, Vimentin and Slug. Conclu-sion :These results suggest that miR -29a could promote TGF -β1 - induced EMT in NSCLC cells through down - regulating PTEN expression.
出处 《现代肿瘤医学》 CAS 2018年第5期653-659,共7页 Journal of Modern Oncology
基金 辽宁省自然科学基金项目(编号:20170540562)
关键词 非小细胞肺癌 miR-29a PTEN 上皮间质转化 non - small cell lung cancer,microRNA - 29a, PTEN,epithelial - mesenchymal transition
  • 相关文献

参考文献6

二级参考文献78

  • 1杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 2Lee JD,Hempel N,Lee NY,et al.The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling[J].Carcinogenesis,2010,31(2):175-183.
  • 3Yan W,Fu Y,Tian D,et al.PI3 kinase/Akt signaling mediates epithelial -mesenchymal transition in hypoxic hepatocellular carcinoma cells[J].Biochem Biophys Res Commun,2009,382(3):631-636.
  • 4Kang MH,Kim JS,Seo JE,et al.BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway[J].Exp Cell Res,2010,316(1):24-37.
  • 5Skurk C,Maatz H,Rocnik E,et al.Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells[J].Circ Res,2005,96(3):308-318.
  • 6Yin L,Velazquez OC,Liu ZJ.Notch signaling:emerging molecular targets for cancer therapy[J].Biochem Pharmacol,2010,80(5):690-701.
  • 7Hurlbut GD,Kankel MW,Lake RJ,et al.Crossing paths with Notch in the hyper-network[J].Curr Opin Cell Biol,2007,19(2):166-175.
  • 8Radtke F,Fasnacht N,MacDonald HR.Notch signaling in the immune system[J].Immunity,2010,32(1):14-27.
  • 9Verkaar F,Zaman GJ.New avenues to target Wnt/β-catenin signaling[J].Drug Discovery Today,2011,16(1):35-41.
  • 10MacDonald BT,Tamai K,He X.Wnt/β-catenin signaling components,mechanisms,and diseases[J].Dev Cell,2009,17(1):9-26.

共引文献164

同被引文献101

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部